Regenxbio | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (17)

View All

Latest Posts

About This Stock More About This Stock
The One-Minute Market Report - Sunday, Feb. 11
Article By: Erik Conley
Sunday, February 11, 2024 4:40 PM EDT
In this brief market report, we will take a look at the various asset classes, sectors, equity categories, exchange-traded funds, and stocks that moved the market higher, as well as the market segments that defied the trend by moving lower.
In this article: SPX Also: PALL, SMCI, TAN, ENPH, RGNX, APPS, URNM, BITO
Read
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, & More
Article By: Benzinga
Sunday, February 6, 2022 3:30 PM EDT
Biotech stocks managed to close the week with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid some big pharma earnings. The sector came back up in the final session for a firm finish.
In this article: MRK, PFE, SNY, RHHBY, BIIB, LOGC, ABBV, RGNX, VTRS, AVRO
Read
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
Article By: Benzinga
Sunday, October 10, 2021 6:00 PM EDT
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets amid the broader market strength.
In this article: LLY, CCXI, XENE, ATRA, CLSD, RGNX, ALLO, PRLD, FDMT, OTLK
Read
5 Gene Therapy Stocks Back In Focus On AbbVie/Regenxbio Deal
Article By: Zacks Investment Research
Tuesday, September 14, 2021 3:32 PM EDT
Gene therapy is set to become one of the most vital spaces with high prospects in the biotech sector.
In this article: SRPT, QURE, SLDB, MGTX, VYGR Also: ABBV, RGNX
Read
18 Key Biopharma Catalysts To Keep An Eye On In Q3
Article By: Benzinga
Saturday, July 10, 2021 3:54 PM EDT
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Here is a look at some catalysts for the biopharam sector in the coming months.
In this article: ZGNX, XENE, AERI, RVNC, ZYNE, CLSD, RGNX, KALV, ACER, VRCA
Read
All Posts

Latest Tweets for $RGNX

No tweets yet!

PARTNER HEADLINES

$RGNX

Comments Status Updates
3 Promising Gene Therapy Stocks
Terry Caruso • 5/27/2019 4:36:22 PM

You left out the big dog, $RGNX

1 to 1 of 1 comments